Keystone Conference 2018

21st Century Drug Discovery and Development for Global Health

17-20 October 2018 
Berlin, Germany

The conference is part of the Keystone Symposia Global Health Series and is supported by the Bill & Melinda Gates Foundation. 



New therapeutics for global health 

Date: Thursday, 18 October 2018
Time: 8:30-10:00
Location: Bordeaux I-II

Transformative new therapies for Human African trypanosomiasis
Nathalie Strub-Wourgaft, NTD Director, DNDi, Geneva

Progress with cipargamin and KAF156 in phase 2 development for treatment of malaria
Thierry T. Diagana, Head of the Novartis Institute for Tropical Diseases, Novartis Institutes for BioMedical Research, USA

Novel drug candidates to address the threat of antibacterial resistance in the developing world; TB and Shigella
Lluís Ballell, Open Lab Head, GlaxoSmithKline, Spain


Importance of chemical diversity in seeking new leads 

Date: Friday, 19 October 2018
Time: 8:30-11:30
Location: Bordeaux I-II

Experience with DNA-encoded libraries in search for new leads against TB and malaria
Ghotas EvindarManager and ELT Hit to Lead Group Leader, GlaxoSmithKline, USA 

Application of data-mining and deep learning to identify new leads from marine natural products
E. Paige Stout, Group Leader, Discovery Chemistry, Sirenas, USA 

Identifying anti-filarial candidates using a multi-faceted screening funnel
Judy A. SakanariAdjunct Professor. Department of Pharmaceutical Chemistry, University of California, San Francisco, USA 

A new era of orally active treatments for leishmaniasis patients
Charles Mowbray, Discovery Director, DNDi, Switzerland 



More information: